Dr. Fanlei Hu, Professor, Deputy Director of Institute of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China. His research interests mainly focus on the “autoantigen-B cells-autoantibody”-based pathogenesis, immune diagnosis and treatment of autoimmune diseases. He has published more than 60 peer reviewed papers as first/corresponding author in reputed journals, including Nature Communications, Science Advances, Annals of the Rheumatic Diseases, et al (H-index: 29). He has been awarded many scientific prizes, including Young investigator of Changjiang Scholars Program of Ministry of Education of China, Chinese Medical Science and Technology Award, and so forth. He is also serving as the Deputy Secretary-General of the Chinese Society of Immunology–Autoimmunity Branch, as well as the Section Editor of Endocrine Metabolic & Immune Disorders-Drug Targets, and the editorial board member of Frontiers in Immunology and Experimental and Therapeutic Medicine.
Early bird registration is open and closes May 2025. Register now
